Peptide Therapy at Flourish

Semaglutide is a GLP-1 receptor agonist used in certain FDA-approved medications. It works through pathways involved in appetite regulation, glucose metabolism, and gastrointestinal signaling. A licensed medical provider will determine whether semaglutide is appropriate based on your individual health history and needs. Compounded semaglutide is not FDA-approved.

Tirzepatide is a GIP/GLP-1 receptor agonist used in certain FDA-approved medications. It acts on pathways involved in appetite regulation, glucose metabolism, and metabolic signaling. A licensed medical provider will determine whether tirzepatide is appropriate based on your individual health history and needs. Compounded tirzepatide is not FDA-approved.

BPC-157 is an investigational peptide that has been studied in relation to tissue-repair, gastrointestinal, and cellular signaling pathways. Most of the research remains preclinical, and human safety and effectiveness data are limited. BPC-157 is not FDA-approved.

The Wolverine Blend is a customized peptide combination designed for practitioner-guided care. The individual components may be discussed in relation to recovery and tissue-related pathways. Your medical provider will determine whether the specific formulation is appropriate for you.

The Glow Peptide Blend is a customized peptide combination formulated for practitioner-guided care. Its components may be discussed in relation to pathways involved in skin and tissue biology. Your medical provider will determine whether this therapy is appropriate for you.

CJC/Ipamorelin refers to peptide compounds studied in relation to growth-hormone signaling. Research has explored their role in pathways associated with recovery, body composition, and metabolic signaling. These compounds are not FDA-approved for general wellness or anti-aging use, and your medical provider will determine whether they are appropriate for you.

Sermorelin is a growth-hormone-releasing hormone analog that has been studied for its role in stimulating the body's natural growth-hormone signaling pathway. Treatment is individualized and should be discussed with a licensed medical provider based on your health history and clinical needs.

MOTS-C is an investigational peptide being studied in relation to mitochondrial and metabolic signaling. Research has explored its potential role in cellular energy and metabolic pathways, but human safety and effectiveness data are currently limited. MOTS-C is not FDA-approved.

NAD+ is a naturally occurring coenzyme involved in cellular energy production and numerous metabolic processes. NAD+ therapy is offered as a practitioner-guided treatment and is considered based on an individual's health history and goals.

GHK-Cu is a naturally occurring copper-binding peptide that has been studied in connection with skin, connective tissue, and cellular signaling pathways, including processes involved in collagen and extracellular-matrix biology. Injectable GHK-Cu is not FDA-approved, and your medical provider will determine whether it is appropriate for you.

Glutathione is an antioxidant naturally produced by the body that plays an important role in cellular redox balance and antioxidant defense. Injectable glutathione may be considered as part of an individualized treatment plan when determined appropriate by a licensed medical provider.

Selank is an investigational peptide that has been studied in relation to neurological and signaling pathways. Research has explored its potential effects on neurological function and stress-related pathways, but human safety and effectiveness data are limited. Selank is not FDA-approved in the United States.

Thymosin Alpha-1 is a peptide that has been studied in connection with immune-system signaling and immune response pathways. It has been investigated in a variety of clinical and research settings, but it is not FDA-approved in the United States. Your medical provider will determine whether it is appropriate for your individual circumstances.